Skip to content
Cyber Threat
CTI Academy Sponsor CTI Academy
Ransomware victim Healthcare

MPA Pharma GmbH

Listed by Metaencryptor on · organisation based in Germany

mpapharma.com

Disclosed
Aug 23, 2026
Leak-site listing date
Threat group
Metaencryptor
55 victims listed
Country
Germany
#2 most targeted
Sector
Healthcare

ThreatAI analysis

Compiled from this incident record and the threat intelligence profile for Metaencryptor. Figures and technique mappings are quoted from the source data, not inferred.

Metaencryptor listed MPA Pharma GmbH on its dark web leak site on 23 August 2026, a company that specializes in importing and trading high-quality pharmaceuticals.

About MPA Pharma GmbH

MPA Pharma GmbH is an internationally active, rapidly growing company specializing in the import and trade of high-quality pharmaceuticals, including both patented and generic products. With over 35 years of expertise in the pharmaceutical market, they also provide contract manufacturing services for third parties. Their primary clients include pharmacies and businesses in need of reliable pharmaceutical and medical products. Revenue $614 Million

Source record: ransomware.live

About the Metaencryptor group

MetaEncryptor is a ransomware group first observed in mid-2023, targeting medium-to-large enterprises in legal, technology, logistics, manufacturing, and finance sectors primarily in the UK, Europe, and Southeast Asia, using AES-256/RSA-2048 encryption and double extortion. Metaencryptor has listed 55 victims since August 2023.

Incident analysis

MPA Pharma GmbH was listed by Metaencryptor ransomware, a group with 55 victims recorded in this database. The listing appeared on the group's leak site on August 23, 2026.

MPA Pharma GmbH is based in Germany and operates in the Healthcare sector. Germany ranks #2 worldwide for ransomware disclosures, with 1,031 victims in this database.

Sector context. Healthcare organisations are high-value ransomware targets because patient data is extremely sensitive, regulatory penalties for breaches are severe, and operational downtime can threaten patient safety — all factors that increase ransom payment pressure.

Metaencryptor typically follows a double extortion model: data is exfiltrated from the victim's systems before files are encrypted, so the victim faces two demands at once — pay to restore access, and pay to keep stolen data unpublished. The leak site, where this listing appeared, is the lever for the second demand.

Source. Public leak-site disclosures aggregated via the ransomware.live API. The disclosure date is when the listing was published, which can differ from the date of compromise. This site does not publish or link to stolen data. Last updated .

Frequently asked questions

Was MPA Pharma GmbH attacked by ransomware?

Yes. MPA Pharma GmbH was listed as a victim of the Metaencryptor ransomware group on August 23, 2026. The organisation is based in Germany and operates in the Healthcare sector. The disclosure appeared on the group's dark web leak site.

Which ransomware group attacked MPA Pharma GmbH?

MPA Pharma GmbH was attacked by Metaencryptor ransomware. Metaencryptor is one of the most active ransomware groups, having claimed 55 victims globally. The group typically employs a double-extortion model: encrypting the victim's files and threatening to publish stolen data.

When did the MPA Pharma GmbH ransomware attack occur?

The ransomware attack on MPA Pharma GmbH was disclosed on August 23, 2026. This date reflects when the victim was published on the threat group's leak site, which may differ from the actual date of initial compromise.

What data was stolen in the MPA Pharma GmbH ransomware attack?

The specific data stolen from MPA Pharma GmbH has not been independently verified by this platform. Ransomware groups typically exfiltrate data before encrypting systems and use the threat of publication to pressure victims. As a Healthcare organisation, MPA Pharma GmbH likely held patient records, medical data, and personally identifiable information (PII).

How can organisations protect against Metaencryptor attacks?

To defend against Metaencryptor and similar threat actors, organisations should: maintain regular offline backups tested for restoration; implement network segmentation to limit lateral movement; deploy multi-factor authentication on all remote access; use endpoint detection and response (EDR) tools; conduct regular phishing and security awareness training; and monitor threat intelligence feeds for indicators of compromise (IOCs) associated with active groups.